We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$666M
Cap. Flow
+$831M
Cap. Flow %
11.61%
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$146M
2
GILD icon
Gilead Sciences
GILD
+$116M
3
AMZN icon
Amazon
AMZN
+$86.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$84.7M
5
ADI icon
Analog Devices
ADI
+$80M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$73.2M
2
PANW icon
Palo Alto Networks
PANW
+$59.8M
3
ALKS icon
Alkermes
ALKS
+$55.3M
4
ACN icon
Accenture
ACN
+$53.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 36.05%
2 Technology 29.2%
3 Financials 8.76%
4 Industrials 7.7%
5 Communication Services 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WWE
326
DELISTED
World Wrestling Entertainment
WWE
$4.34M 0.06%
61,843
+15,911
+35% +$1.08M
ABOS icon
327
Acumen Pharmaceuticals
ABOS
$164M
$4.33M 0.06%
432,158
+5,988
+1% +$34.3K
PCOR icon
328
Procore
PCOR
$8.34B
$4.33M 0.06%
87,490
-238,192
-73% -$12.8M
SPRY icon
329
ARS Pharmaceuticals
SPRY
$547M
$4.29M 0.06%
+812,899
New +$4.01M
POOL icon
330
Pool Corp
POOL
$7.32B
$4.28M 0.06%
+13,449
New +$4.8M
AHRN
331
DELISTED
Ahren Acquisition Corp
AHRN
$4.27M 0.06%
425,000
+300,000
+240% +$3M
CFLT
332
DELISTED
Confluent
CFLT
$4.17M 0.06%
+175,556
New +$4.73M
KAHC
333
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$4.17M 0.06%
423,491
+348,491
+465% +$3.42M
AMBA icon
334
Ambarella
AMBA
$3.68B
$4.11M 0.06%
+73,158
New +$5.42M
GLUE icon
335
Monte Rosa Therapeutics
GLUE
$1.33B
$4.11M 0.06%
502,411
+126,403
+34% +$1.16M
CINC
336
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$4.1M 0.06%
+125,050
New +$3.53M
TMUS icon
337
T-Mobile US
TMUS
$193B
$4.09M 0.06%
30,460
-121,120
-80% -$17M
OHAAU
338
DELISTED
OPY Acquisition Corp. I Units
OHAAU
$3.98M 0.06%
400,000
– –
BEAM icon
339
Beam Therapeutics
BEAM
$2.81B
$3.96M 0.06%
+83,134
New +$4.74M
OM icon
340
Outset Medical
OM
$96.2M
$3.94M 0.06%
16,497
+273
+2% +$73.1K
CLDI icon
341
Calidi Biotherapeutics
CLDI
$2.12M
$3.94M 0.06%
208
-823
-80% -$15.8M
AONC
342
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$3.93M 0.05%
400,000
– –
ARYE
343
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$3.92M 0.05%
400,000
– –
VRNA
344
DELISTED
Verona Pharma
VRNA
$3.83M 0.05%
375,033
-126,425
-25% -$1.07M
CLAA
345
DELISTED
Colonnade Acquisition Corp. II
CLAA
$3.83M 0.05%
386,122
– –
THRD
346
DELISTED
Third Harmonic Bio
THRD
$3.79M 0.05%
+200,063
New +$3.61M
EHAB
347
DELISTED
Enhabit
EHAB
$3.79M 0.05%
+269,638
New +$4.37M
VAQC
348
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$3.76M 0.05%
379,501
– –
ESM
349
DELISTED
ESM Acquisition Corporation
ESM
$3.72M 0.05%
375,026
– –
KURA icon
350
Kura Oncology
KURA
$822M
$3.66M 0.05%
267,683
– –
12 13
14
15 16

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.

  • Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
  • Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
  • Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
  • Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
  • Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
  • Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
  • Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.